MyFinsight
Home
Blog
About
Contact
Download
Download image
Fixed Price
Contract-Implants-Sales Channel Through...
$41,507K
Fixed Price
Contract-Implants-Provideror Facility
$7,409K
Implants-Sales Channel Through
Intermediary-Time And Materials...
$4,788K
Implants-Time And Materials
Contract
$2,074K
Biopsy Kits-Sales
Channel Directly To...
$606K
Change In Accounting
Method Accounted For As...
$14K
Interest income
$1,851K
(11.71%↑ Y/Y)
product sales,
net-maciimplants and...
$56,398K
product sales,
net-epicel-sales channel...
$10,885K
nexobrid-nexo
brid-provideror facility-Nexo...
$1,142K
Other income
$71K
(69.05%↑ Y/Y)
Net loss
-$6,302K
(43.96%↑ Y/Y)
Total other income
$1,762K
(13.97%↑ Y/Y)
Total revenue
$68,425K
(30.09%↑ Y/Y)
Interest expense
$160K
(4.58%↑ Y/Y)
Loss from operations
-$8,064K
(36.96%↑ Y/Y)
Gross profit
$49,266K
(35.82%↑ Y/Y)
Cost of product sales
$19,159K
(17.36%↑ Y/Y)
Total operating
expenses
$57,330K
(16.85%↑ Y/Y)
Selling, general and
administrative
$49,226K
(17.75%↑ Y/Y)
Research and development
$8,104K
(11.61%↑ Y/Y)
Back
Back
Income Statement
Vericel Corp (VCEL)
Vericel Corp (VCEL)
source: myfinsight.com